Pfizer (PFE) and Arvinas (ARVN) aim to seek FDA approval for thier breast cancer therapy vepdegestrant in H2 2025. Read more ...

Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...

The use of Gilead’s Trodelvy and Merck’s Keytruda together could be practice-changing based on the results of a new study ...

“The AI test has a negligible failure rate, while current genomic tests have a failure rate of 20% to 30%, necessitating ...

Team awarded $2.5 million grant to develop system for inserting tiny light-emitting fibers directly into tumors.

Bioengineering assistant professor Girgis Obaid at the University of Texas at Dallas and cancer researcher Rolf Brekken at UT ...

Advancements in prostate cancer screening may be contributing to more reported cases, but are men being overdiagnosed?

Researchers at UC San Diego, led by Professor Trey Ideker (right) are included in a $142 million initiative from ARPA-H with ...

Researchers have developed new software that allows clinicians to design personalized treatments for patients with movement ...

Meghan McCain is standing by the Bidens after former President Joe Biden was diagnosed with an "aggressive form" of prostate ...

The Trump administration's cuts to medical research grants have disrupted awards once backed by former President Joe Biden's ...